GSK Plc Form 6-K Summary: Performance Share Plan Vesting
Business Context and Reporting Period
This Form 6-K, filed on February 21, 2025, discloses the vesting of Performance Share Plan (PSP) awards granted in February 2022 to Persons Discharging Managerial Responsibilities (PDMRs) and their Persons Closely Associated (PCAs). The performance period covered January 1, 2022, through December 31, 2024. Vested shares are subject to an additional two-year holding period.
Key Financial Metrics and Performance Outcomes
The filing details the achievement of specific performance metrics used to calculate vesting levels for the 2022 awards. The total vesting level achieved was 80.75%, with 19.25% of the award lapsed.
| Performance Measure | Weight | Outcome | Vesting Level |
|---|---|---|---|
| Total Shareholder Return (TSR) | 30% | Ranked 5th out of 10 comparator companies | 12% of maximum |
| Total Sales | 20% | £86.15bn achieved (Target: £80.29bn) | 100% of maximum |
| Total Profit | 20% | £24.2bn achieved (Target: £23.62bn) | 100% of maximum |
| Pipeline Progress | 20% | 87.5% achievement based on trial starts and approvals | 87.5% of maximum |
| Trust: Environment | 10% | Criteria for Nature Net Positive and Climate Net Zero met/exceeded | 100% of maximum |
Market Data on Vesting Date (Feb 18, 2025):
- Ordinary Share Closing Price: £14.43
- American Depositary Share (ADS) Closing Price: $36.61
Material Changes and Transactions
The filing reports specific transactions executed on February 18, 2025, for various executives. These include the vesting of shares/ADSs and subsequent sales to meet tax liabilities. The filing does not report changes to the company's overall financial position, debt, or liquidity, as it is a disclosure of executive compensation events.
Notable Transactions:
- Emma Walmsley (CEO): 420,177 Ordinary Shares vested.
- Diana Conrad (Chief People Officer): 88,027 Ordinary Shares vested; 47,121 shares sold at £14.2531 to cover taxes.
- Shobie Ramakrishnan (Chief Digital and Technology Officer): 47,681 ADSs vested; 25,705 ADSs sold at $36.6355 to cover taxes.
- Other Executives: Similar vesting and tax sale transactions were reported for James Ford, Sally Jackson, Luke Miels, David Redfern, Regis Simard, Phil Thomson, Deborah Waterhouse, Tony Wood, and Victoria Whyte.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future strategy, or specific risk factors beyond the standard disclosure of executive compensation. The primary "risk" noted is the lapse of 19.25% of the 2022 awards due to performance conditions not being fully met, specifically regarding Total Shareholder Return and Pipeline Progress.
Investor Verification Checklist
- Performance Metrics: Verify the £86.15bn sales and £24.2bn profit figures against the company's full-year 2024 audited financial statements.
- TSR Ranking: Confirm the methodology and comparator group used for the Total Shareholder Return ranking (5th out of 10).
- Share Count: Reconcile the total number of shares vested and sold by PDMRs against the company's insider trading reports and share capital changes.
- Hold Period: Note that vested shares are subject to a two-year hold, meaning they will not be freely tradable by executives until 2027.